325 related articles for article (PubMed ID: 26401053)
41. A new FRDA mouse model [
Kalef-Ezra E; Edzeamey FJ; Valle A; Khonsari H; Kleine P; Oggianu C; Al-Mahdawi S; Pook MA; Anjomani Virmouni S
Front Neurosci; 2023; 17():930422. PubMed ID: 36777637
[TBL] [Abstract][Full Text] [Related]
42. Repeat expansion affects both transcription initiation and elongation in friedreich ataxia cells.
Kumari D; Biacsi RE; Usdin K
J Biol Chem; 2011 Feb; 286(6):4209-15. PubMed ID: 21127046
[TBL] [Abstract][Full Text] [Related]
43. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
[TBL] [Abstract][Full Text] [Related]
44. Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy.
Sandi C; Al-Mahdawi S; Pook MA
Genet Res Int; 2013; 2013():852080. PubMed ID: 23533785
[TBL] [Abstract][Full Text] [Related]
45. Generation of two human induced pluripotent stem cell lines, IGIBi012-A and IGIBi013-A from Friedreich's ataxia (FRDA) patients with homozygous GAA repeat expansion in FXN gene.
Ahmad I; Kapoor H; Srivastava AK; Faruq M
Stem Cell Res; 2024 Apr; 76():103340. PubMed ID: 38367363
[TBL] [Abstract][Full Text] [Related]
46. Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability.
Ku S; Soragni E; Campau E; Thomas EA; Altun G; Laurent LC; Loring JF; Napierala M; Gottesfeld JM
Cell Stem Cell; 2010 Nov; 7(5):631-7. PubMed ID: 21040903
[TBL] [Abstract][Full Text] [Related]
47. Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia.
Gottesfeld JM
Neurotherapeutics; 2019 Oct; 16(4):1032-1049. PubMed ID: 31317428
[TBL] [Abstract][Full Text] [Related]
48. Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich's Ataxia.
Soragni E; Chou CJ; Rusche JR; Gottesfeld JM
Front Neurol; 2015; 6():44. PubMed ID: 25798128
[TBL] [Abstract][Full Text] [Related]
49. Friedreich's ataxia GAA.TTC duplex and GAA.GAA.TTC triplex structures exclude nucleosome assembly.
Ruan H; Wang YH
J Mol Biol; 2008 Nov; 383(2):292-300. PubMed ID: 18775729
[TBL] [Abstract][Full Text] [Related]
50. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.
Libri V; Yandim C; Athanasopoulos S; Loyse N; Natisvili T; Law PP; Chan PK; Mohammad T; Mauri M; Tam KT; Leiper J; Piper S; Ramesh A; Parkinson MH; Huson L; Giunti P; Festenstein R
Lancet; 2014 Aug; 384(9942):504-13. PubMed ID: 24794816
[TBL] [Abstract][Full Text] [Related]
51. DNA methylation in Friedreich ataxia silences expression of frataxin isoform E.
Rodden LN; Gilliam KM; Lam C; Rojsajjakul T; Mesaros C; Dionisi C; Pook M; Pandolfo M; Lynch DR; Blair IA; Bidichandani SI
Sci Rep; 2022 Mar; 12(1):5031. PubMed ID: 35322126
[TBL] [Abstract][Full Text] [Related]
52. Influence of Friedreich ataxia GAA noncoding repeat expansions on pre-mRNA processing.
Baralle M; Pastor T; Bussani E; Pagani F
Am J Hum Genet; 2008 Jul; 83(1):77-88. PubMed ID: 18597733
[TBL] [Abstract][Full Text] [Related]
53. Selected Histone Deacetylase Inhibitors Reverse the Frataxin Transcriptional Defect in a Novel Friedreich's Ataxia Induced Pluripotent Stem Cell-Derived Neuronal Reporter System.
Schreiber AM; Li Y; Chen YH; Napierala JS; Napierala M
Front Neurosci; 2022; 16():836476. PubMed ID: 35281493
[TBL] [Abstract][Full Text] [Related]
54. SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia.
Bon C; Luffarelli R; Russo R; Fortuni S; Pierattini B; Santulli C; Fimiani C; Persichetti F; Cotella D; Mallamaci A; Santoro C; Carninci P; Espinoza S; Testi R; Zucchelli S; Condò I; Gustincich S
Nucleic Acids Res; 2019 Nov; 47(20):10728-10743. PubMed ID: 31584077
[TBL] [Abstract][Full Text] [Related]
55. Small molecules affecting transcription in Friedreich ataxia.
Gottesfeld JM
Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
[TBL] [Abstract][Full Text] [Related]
56. Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.
Bandiera S; Cartault F; Jannot AS; Hatem E; Girard M; Rifai L; Loiseau C; Munnich A; Lyonnet S; Henrion-Caude A
PLoS One; 2013; 8(1):e54791. PubMed ID: 23382970
[TBL] [Abstract][Full Text] [Related]
57. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model.
Rai M; Soragni E; Chou CJ; Barnes G; Jones S; Rusche JR; Gottesfeld JM; Pandolfo M
PLoS One; 2010 Jan; 5(1):e8825. PubMed ID: 20098685
[TBL] [Abstract][Full Text] [Related]
58. Molecular approaches for the treatment and prevention of Friedreich's ataxia.
Yang W; Thompson B; Kwa FAA
Drug Discov Today; 2022 Mar; 27(3):866-880. PubMed ID: 34763067
[TBL] [Abstract][Full Text] [Related]
59. Pitfalls in molecular diagnosis of Friedreich ataxia.
Barcia G; Rachid M; Magen M; Assouline Z; Koenig M; Funalot B; Barnerias C; Rötig A; Munnich A; Bonnefont JP; Steffann J
Eur J Med Genet; 2018 Aug; 61(8):455-458. PubMed ID: 29530802
[TBL] [Abstract][Full Text] [Related]
60. Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia.
Grant L; Sun J; Xu H; Subramony SH; Chaires JB; Hebert MD
FEBS Lett; 2006 Oct; 580(22):5399-405. PubMed ID: 16989817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
